Institutional Career Development Core

自2008年成立以来，犹他州CCTS KL 2计划的基本原理一直是通过提供 有前途的初级教师研究人员与多方面的指导研究经验，使他们能够 发展、展示和传播转化科学，以促进健康。该计划吸引了学者 从七个犹他州CCTS合作机构的大量候选人中， 研究成功。最终的结果是创建了一个多元化的科学家团队，他们影响了当地和国家 从出生到生命结束的医疗保健优先事项。项目的影响通过研究生产力来证明， 67%的过去的学者获得了额外的职业发展奖，并共同发表了317篇论文。 手稿与7,094引文（平均H指数= 9.8）。 犹他州KL 2计划未来五年的目标是培养有前途的初级教师 取得研究成功。虽然研究成功的典型决定因素是达到R 01 在国家卫生研究院的支持下，我们扩大了K到研究成功的定义，包括领导一个科学的 研究企业> 200，000美元的年度支持，并进行具有重大影响的研究 健康和医疗保健。我们将通过以下三个目标实现这一目标： 目标1：提高KL 2学者达到“K to R等效成功”的比例，包括 在R 01等效奖励的5年内增加PI的比例（从17%增加到50%） 完成他们的指导培训奖。 目标2增加犹他州CCTS KL 2学者的数量，他们在医学（URM）中的代表性不足。 目标3：积极加强和扩大现有临床和转化科学事业的使用 犹他州CCTS生态系统和国家CTSA网络内的发展机会。 关键程序设计功能包括大学副校长的临床和转化科学 （VPCAT）计划。这两年的密集经验提供了课程和指导的基础， KL 2学者通过使用整体矩阵指导模型，制定个人发展计划 (IDP)以及主要研究者管理要点培训©。我们将在这些功能的基础上， 实现我们的既定目标，1）建立一个专门设计的机构基础设施，以支持新的 调查人员追求R 01，2）实施有针对性的招聘那些在医学界代表性不足 从博士前水平开始，3）扩大使用犹他州CCTS社区外展资源， 加强与CTSA其他项目的联系。犹他州KL 2董事、指导委员会和 外部咨询委员会将为该计划提供指导，因为它从两个扩展到四个NCATS 支持学者，重点是增加群体的多样性。此外，我们还将添加 第三年的选择支持学者谁额外的资金将是变革。

Since its inception in 2008, the Utah CCTS KL2 Program rationale has been to distinguish itself by providing promising junior faculty researchers with multidimensional mentored research experiences that enable them to develop, demonstrate, and disseminate translational science to advance health. The program draws scholars from the large pool of candidates in the seven Utah CCTS partnering institutions and provides a path to research success. The end result is the creation of a diverse team of scientists who impact local and national healthcare priorities from birth to end of life. Program impact is demonstrated by research productivity where 67% of past scholars have received additional career development awards and collectively have published 317 manuscripts with 7,094 citations (average H-index = 9.8). The objective of the Utah KL2 program for the next five years is to have promising junior faculty members achieve research success. While the typical determinant of research success is attainment of R01 level NIH support, we broaden the definition of K to Research success to include leading a scientific research enterprise of >$200,000 in annual support and conducting research with substantial impact on health and healthcare. We will realize this objective with the following three aims: Aim 1: Improve the proportion of KL2 scholars who achieve “K to R equivalent Success”, including increasing the proportion (from 17% to 50%) who are the PI on an R01 equivalent award within 5 years of completing their mentored training award. Aim 2 Increase the number of Utah CCTS KL2 Scholars who are underrepresented in medicine (URM). Aim 3: Proactively strengthen and expand use of existing clinical and translational science career development opportunities within the Utah CCTS ecosystem and the national CTSA network. Key program design features include the University’s Vice President’s Clinical and Translational science (VPCAT) program. This two year intensive experience provides the curricular and mentoring foundation for KL2 scholars by using the holistic Matrix Mentoring Model, development of an Individual Development Plans (IDP), and training in Management Essentials for Principal Investigators©. We will build on these features to accomplish our stated aims by 1) creating an institutional infrastructure specifically designed to support new investigators in pursuit of R01s, 2) implementing targeted recruitment of those underrepresented in medicine beginning at the pre-doctoral level, and 3) expand use of Utah CCTS community outreach resources and augment links with other CTSA programs. The Utah KL2 directors, Steering Committee, and established External Advisory Board will provide guidance for the program as it expands from two to four NCATS supported scholars, with a focus on increasing the diversity of the group. In addition, we will also add the option for a third year of support for scholars for whom the additional funding would be transformative.